# OGIVRI
> **BLA761074** · Biologics License Application · Sponsor: MYLAN GMBH · Approved 2017-12-01
## Drug
- **FDA Application Number:** BLA761074
- **Application type:** Biologics License Application
- **Brand name:** OGIVRI
- **Generic name:** TRASTUZUMAB-DKST
- **Active ingredients:** TRASTUZUMAB-DKST
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MYLAN GMBH
- **Manufacturer:** Biocon Biologics Inc.
- **First approval:** 2017-12-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761074)
---
*MORVS · CC0 1.0*